Single-arm, phase II study to evaluate the safety and efficacy of sacituzumab govitecan in patients with metastatic castration-resistant prostate cancer who have progressed on second generation AR-directed therapy Meeting Abstract
| Authors: | Lang, J. M.; Kyriakopoulos, C.; Slovin, S. F.; Eickhoff, J. C.; Dehm, S.; Tagawa, S. T. |
| Abstract Title: | Single-arm, phase II study to evaluate the safety and efficacy of sacituzumab govitecan in patients with metastatic castration-resistant prostate cancer who have progressed on second generation AR-directed therapy |
| Meeting Title: | 2020 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2020 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-20 |
| Language: | English |
| ACCESSION: | WOS:000529525900004 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.6_suppl.TPS251 |
| Notes: | Meeting Abstract: TPS251 -- Source: Wos |
